Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arca Biopharma (ABIO)
NASDAQ:ABIO
Arca Biopharma (ABIO) Stock Price & Analysis
451 Followers
ABIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.56 - $3.88
Previous Close$3.4
Volume225.75K
Average Volume (3M)1.44M
Market Cap
$48.87M
Enterprise Value$12.08M
Total Cash (Recent Filing)$37.43M
Total Debt (Recent Filing)$204.00K
Price to Earnings (P/E)-9.2
Beta0.06
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding14,501,143
10 Day Avg. Volume356,303
30 Day Avg. Volume1,435,643
Standard Deviation0.34
R-Squared0.03
Alpha-0.00633
Financial Highlights & Ratios
Price to Book (P/B)1.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arca Biopharma News
PremiumCompany Announcements
Arca Biopharma Announces Executive Leadership Transition
PremiumCompany Announcements
Arca Biopharma’s Strategic Merger with Oruka Therapeutics
PremiumCompany Announcements
Arca Biopharma Board Reshuffle as Two Directors Depart
PremiumPress Releases
ARCA biopharma Announces 2023 Financial Results
PremiumCompany Announcements
Arca Biopharma Stockholders Approve Board Elections and Executive PayRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABIO FAQ
What was Arca Biopharma’s price range in the past 12 months?
Arca Biopharma lowest stock price was $1.56 and its highest was $3.88 in the past 12 months.
What is Arca Biopharma’s market cap?
Currently, no data Available
When is Arca Biopharma’s upcoming earnings report date?
Arca Biopharma’s upcoming earnings report date is May 08, 2024 which is in 16 days.
How were Arca Biopharma’s earnings last quarter?
Arca Biopharma released its earnings results on Feb 01, 2024. The company reported -$0.075 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.075.
Is Arca Biopharma overvalued?
According to Wall Street analysts Arca Biopharma’s price is currently Overvalued.
Does Arca Biopharma pay dividends?
Arca Biopharma does not currently pay dividends.
What is Arca Biopharma’s EPS estimate?
Arca Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arca Biopharma have?
Arca Biopharma has 14,501,143 shares outstanding.
What happened to Arca Biopharma’s price movement after its last earnings report?
Arca Biopharma reported an EPS of -$0.075 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.532%.
Which hedge fund is a major shareholder of Arca Biopharma?
Among the largest hedge funds holding Arca Biopharma’s share is Western Standard Llc. It holds Arca Biopharma’s shares valued at 2M.
---
Arca Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.71%
12-Months-Change
Fundamentals
Return on Equity
-13.57%
Trailing 12-Months
Asset Growth
-12.12%
Trailing 12-Months
Company Description
Arca Biopharma
ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
---
Technical Analysis
---